The French Competition Authority issues opinion following its sector inquiry on the distribution of medicinal products

After gathering market players' insight, and having carried out an in-depth analysis of how the sector operates, the Autorité de la concurrence publishes its opinion.*It calls for the stimulation of competition throughout the distribution chain, and in particular supports the supervised opening up of the retail distribution of medicinal products that are not reimbursed. In February 2013, the Autorité de la concurrence took the initiative of launching a vast sector inquiry in order to examine the distribution of medicinal products for human use in private practices. A number of factors have led the Autorité to study this area more closely, including the magnitude of the healthcare sector in the national economy, the decision-making practices of competition authorities worldwide and

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

French Competition Authority, The French Competition Authority issues opinion following its sector inquiry on the distribution of medicinal products, 19 December 2013, e-Competitions Bulletin December 2013, Art. N° 67961

Visites 266

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues